Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Haemonetics Corporation Common Stock (NY: HAE )

68.30 +0.83 (+1.23%)
Official Closing Price Updated: 7:00 PM EDT, Mar 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Haemonetics Corporation Common Stock

< Previous 1 2 3 4 5 Next >
Analysts Take Bullish Stance On Haemonetics, Cites Plasma Momentum As Catalyst
Via Benzinga
Haemonetics: Q2 Earnings Insights
Haemonetics (NYSE:HAE) reported its Q2 earnings results on Monday, November 7, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings Haemonetics beat estimated earnings... 
Via Benzinga
Expert Ratings for Haemonetics
Over the past 3 months, 6 analysts have published their opinion on Haemonetics (NYSE:HAE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Leading Medical Stocks, Including Sensus And Shockwave, Have Grown At Least 36% This Year
Biotech isn't the only place to make money in health care this year. 
Via Investor's Business Daily
Cutera Stock Earns Relative Strength Rating Upgrade
On Monday, medical aesthetic Cutera stock had its Relative Strength (RS) Rating upgraded to 90 from 80 a day earlier. 
Via Investor's Business Daily
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
Via Benzinga
Watch for Continued Gains in Shares of Haemonetics Corporation (HAE)
Via Investor Brand Network
Where Haemonetics Stands With Analysts
  Within the last quarter, Haemonetics (NYSE:HAE) has observed the following analyst ratings: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
Upgrades 
Via Benzinga
Haemonetics: Q1 Earnings Insights
  Haemonetics (NYSE:HAE) reported its Q1 earnings results on Wednesday, August 10, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Haemonetics Stock Near Buy Zone With EPS Due
With its next earnings report scheduled for around Aug. 10, Haemonetics stock is trading about 10% shy of a 75.44 buy point. 
Via Investor's Business Daily
Raymond James Thinks Haemonetics Growth Is 'Underappreciated'
Via Benzinga
Stock Market Rally Rises On Inflation Data; Nvidia, Micron, Tesla, Disney In Focus: Weekly Review
The major indexes continued to advance, despite some key warnings. 
Via Investor's Business Daily
Haemonetics Surges Closer To A Breakout After Squashing Quarterly Estimates, Raising Guidance
The blood and plasma supplies provider also raised its sales guidance for the fiscal year. 
Via Investor's Business Daily
InMode Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold
On Tuesday, InMode stock got a positive adjustment to its Relative Strength (RS) Rating, to 86 from 72 a day earlier. 
Via Investor's Business Daily
ShockWave Medical Stock Scores Rising Price Performance With Jump To 92 RS Rating
ShockWave Medical stock saw a welcome improvement to its Relative Strength (RS) Rating on Monday, with an increase from 81 to 92. 
Via Investor's Business Daily
Haemonetics: Q4 Earnings Insights
Haemonetics (NYSE:HAE) reported its Q4 earnings results on Tuesday, May 10, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Analyst Ratings For Haemonetics
Analysts have provided the following ratings for Haemonetics (NYSE:HAE) within the last quarter: 
Via Benzinga
Why Haemonetics Shares Are Trading Higher Today?
Haemonetics Corporation (NYSE: HAE) posted  
Via Benzinga
Morgan Stanley Maintains Equal-Weight Rating for Haemonetics: Here's What You Need To Know
Morgan Stanley has decided to maintain its Equal-Weight rating of Haemonetics (NYSE:HAE) and raise its price target from $60.00 to $70.00. Shares of Haemonetics are trading up 1.46% over the last 24... 
Via Benzinga
4 Analysts Have This to Say About Haemonetics
Over the past 3 months, 4 analysts have published their opinion on Haemonetics (NYSE:HAE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Needham Sees Reasonable Forecasts For Haemonetics, With Some Tailwinds
Haemonetics Corporation's (NYSE: HAE) analyst day later this month may include an update on its businesses, new products, margin outlook, and financial targets for FY24-FY26. 
Via Benzinga
ShockWave Medical Stock Shows Rising Price Performance With Jump To 91 RS Rating
On Monday, ShockWave Medical stock received an upgrade to its Relative Strength (RS) Rating, from 86 to 91. 
Via Investor's Business Daily
The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More
Biotech stocks declined yet again in the week ending May 6, dragged lower by macroeconomic concerns following the Federal Reserve's 50-basis-point rate hike. The iShares Biotechnology ETF (NASDAQ:... 
Via Benzinga
103 Biggest Movers From Yesterday
Gainers 
Via Benzinga
77 Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Cowen & Co. cut the price target on Chipotle Mexican Grill, Inc. (NYSE: CMG) from $2,250 to $1,950. Chipotle shares rose 6.1% to $1,549.97 in pre-market trading. 
Via Benzinga
51 Biggest Movers From Yesterday
Also check out this: Apple And 3 Other Stocks Sold By Insiders Losers SelectQuote, Inc. (NYSE: SLQT) shares tumbled 47.3% to close at $3.44 on Tuesday after the company... 
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Surges 100 Points; Graham Shares Plunge
US stocks extended gains later in the session, with the Nasdaq index surging 100 points on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers BioCardia (NASDAQ:BCDA) stock inc... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.